What is testicular NASP (Nuclear Autoantigenic Sperm Protein)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

What is Testicular NASP?

Testicular NASP (Nuclear Autoantigenic Sperm Protein) is a histone-binding protein of 787 amino acids that is predominantly localized in primary spermatocytes and round spermatids, playing a role in regulating early spermatogenesis events. 1

Molecular Structure and Function

NASP is encoded by a cDNA containing 2,561 nucleotides that produces a protein of 787 amino acids. The molecule contains:

  • Multiple histone-binding domains: At least three functional domains located at amino acids 32-192,193-352, and 353-572 that bind to somatic core histones through both sequence-specific and electrostatic interactions 2
  • Nuclear translocation signal: Completely conserved across species, allowing nuclear localization 1
  • High homology with Xenopus N1/N2: 85% identity with rabbit NASP and extensive conservation with the Xenopus histone-binding protein 1

Cellular Localization in Testis

In human testicular tissue, NASP demonstrates specific distribution patterns:

  • Primary expression sites: Predominantly found in primary spermatocytes and round spermatids 1
  • Absent in: Spermatogonia, Sertoli cells, Leydig cells, peritubular cells, and other somatic cells 1
  • Sperm localization: Present in the acrosomal region of mature spermatozoa, with some remaining in equatorial and postacrosomal regions following the acrosome reaction 1

Two Isoforms Exist

Human NASP exists as two splicing variants:

  • Testicular NASP (tNASP): The longer 787 amino acid form, originally thought to be testis-specific but actually ubiquitously produced in various human tissues 3
  • Somatic NASP (sNASP): A shorter version with two deletions in the coding region from alternative splicing 4

Key functional difference: tNASP shows extremely low nucleosome assembly activity with canonical histones H3.1 or H3.2, but substantial activity with the replacement histone H3.3 variant, specifically through the H3.3 Ile89 residue 3

Clinical Relevance

Autoimmune target: NASP is highly autoimmunogenic, with most vasectomized men developing autoantibodies against it 5. The antigenic sites are preferentially located within amino acids 32-352 and 572-787, with multiple linear epitopes identified in the C-terminal domain (amino acids 648-688) 5.

Proposed Biological Role

NASP functions as a histone transport and binding protein that may regulate early spermatogenesis events, potentially facilitating chromatin remodeling during sperm development 1, 2. The protein's ability to bind histones and its specific localization pattern suggest involvement in the unique chromatin reorganization that occurs during spermatogenesis.

References

Related Questions

Can anxiety cause constipation?
What vitamin D (cholecalciferol) dose should be given based on serum 25‑hydroxyvitamin D level (deficiency, insufficiency, or normal)?
Why is intravenous milrinone administered?
What nutritional therapy is recommended for patients with Graves disease?
In a heart failure patient with elevated serum creatinine (eGFR ≥30 mL/min/1.73 m²), how should sacubitril/valsartan (angiotensin receptor‑neprilysin inhibitor) be initiated, titrated, and monitored?
In the SINGLE‑AF trial, for the no‑anticoagulant arm, how long was temporary anticoagulation permitted around cardioversion or other invasive cardiac procedures, and what happened if anticoagulation exceeded this period—were patients still considered part of the no‑anticoagulant group?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.